Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.34 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | CHRNE | Q04844 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | NQO2 | P16083 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153671 | 0.95 | SMN1; SMN2 (0.33) | SMN1; SMN2KIF11GPR3 | |
| SCHEMBL10313369 | 0.92 | SMN1; SMN2 (0.36) | SMN1; SMN2ALKBH5FTOKIF11PGR | |
| SCHEMBL10153666 | 0.87 | SMN1; SMN2 (0.33) | SMN1; SMN2KIF11GPR3 | |
| SCHEMBL10153680 | 0.69 | EGFR (0.31) | KIF11PGR | |
| SCHEMBL10153508 | 0.69 | GPR3 (0.40) | SMN1; SMN2ALKBH5FTOKIF11GPR3 | |
| SCHEMBL10313361 | 0.69 | ALKBH5 (0.55) | SMN1; SMN2ALKBH5FTOGPR3KDM4E | |
| SCHEMBL10153750 | 0.67 | MAPT (0.39) | SMN1; SMN2PGRKDM4EMAPT | |
| SCHEMBL10153711 | 0.67 | ALKBH5 (0.41) | SMN1; SMN2ALKBH5FTOGPR3KDM4E | |
| SCHEMBL10313364 | 0.67 | SLC6A2 (0.41) | SMN1; SMN2ALKBH5FTOGPR3KDM4E | |
| SCHEMBL10153728 | 0.65 | ACHE (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | SMN1; SMN2 3198/4885ALKBH5 1559/4885FTO 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.